Stockholders' Equity

6 Months Ended

Sep. 27, 2024

Stockholders' Equity Note [Abstract]

Stockholders' Equity

Stockholders' Equity

Dividends

On October 30, 2024, we announced that our Board of Directors declared a cash dividend of $0.125 per share of common stock to be paid in December 2024. All shares of common stock issued and outstanding and all restricted stock units (RSUs) and performance-based restricted stock units (PRUs) as of the record date will be entitled to the dividend and dividend equivalent rights, respectively, which will be paid out if and when the underlying shares are released. However, the 4 million unvested RSUs assumed in connection with the acquisition of Avast will not be entitled to DERs. See Note 14 for further information about these equity awards. Any future dividends and DERs will be subject to the approval of our Board of Directors.

Stock repurchase program

In May 2024, our Board of Directors authorized a new stock repurchase program through which we may repurchase shares of our common stock in an aggregate amount of up to $3 billion with no fixed expiration. Under our stock repurchase program, we may purchase shares of our outstanding common stock on the open market and through accelerated stock repurchase transactions. As of September 27, 2024, we had $2,728 million remaining under the authorization to be completed in future periods.

The following table summarizes activity related to our stock repurchase program during six months ended September 27, 2024 and September 29, 2023:

	Six Months Ended
(In millions, except per share amounts)	September 27, 2024		September 29, 2023
Number of shares repurchased	11		3
Average price per share	$	24.65	$	16.71
Aggregate purchase price	$	272	$	41

We did not have any stock repurchases during the three months ended September 27, 2024 and September 29, 2023.

Accumulated other comprehensive income (loss)

Accumulated other comprehensive income (loss), net of taxes, consisted of foreign currency translation adjustments and unrealized gain (loss) on derivative instruments:

(In millions)	Foreign Currency Translation Adjustments		Unrealized Gain (Loss) On Derivative Instruments		Total
Balance as of March 29, 2024	$	(5)	$	16	$	11
Other comprehensive income (loss), net of taxes	22		(19)		3
Balance as of September 27, 2024	$	17	$	(3)	$	14